People with PTSD (post-traumatic stress disorder) often suffer from depression and bouts of suicidal ideations. Research shows these people can treat this depression with marijuana.
The University of British Columbia and the B.C Centre of Substance use (BCCSU) conducted a study that shows that pot could be used to treat PTSD-induced depression.
The study researchers analyzed data of 24,000 Canadians from Statistics Canada. Their findings were published in the Journal of Psychopharmacology.
The researchers found that people who used marijuana did not suffer from PTSD-induced depression, but those who did not consume marijuana were found to have significant episodes of depression and suicidal tendencies. The BCCSU researchers suggest that people with PTSD should use cannabis for its therapeutic effects.
A PhD candidate at the University of British Columbia and research associate at the BCCSU, Stephanie Lake, said that due to the limited options for treating PTSD effectively, patients are self-medicating with marijuana to manage their symptoms.
Before this study, there was no evidence to show that the therapeutic effects of marijuana could be used for patients with PTSD. The study finding gives PTSD patients new hope when seeking alternative treatment options.
The researchers say that the data from Statistics Canada shows that there is a correlation between trauma from injury, violence, and disaster, and depression and suicide. The researchers further noted that Canada has one of the highest rates of PTSD, with 9.2 percent of the population suffering from the condition.
From 24,000 eligible participants, the researchers found that 420 (1.7%) had a current diagnosis of PTSD. Of the 420, twenty percent reported having used marijuana within the past year. 11 percent of the 420 did not use marijuana in the past year.
Compared to non-marijuana users without PTSD, chances of experiencing depression or suicidal thoughts were seven times more in people who did not use marijuana and were suffering from PTSD.
According to the study, PTSD sufferers who used marijuana were not associated with recent episodes of depression or thoughts of suicide.
The researchers also found that people using marijuana and have post-traumatic stress disorder comprised of more than a quarter of all Canadian citizens. The percentage of people with PTSD and using marijuana is estimated at 11.4 percent.
The study provides evidence of the effective use of cannabis in reducing the possibility of depression and suicidal tendencies among patients with post-traumatic stress disorder. These findings must be good news to marijuana industry players like Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and Mustgrow Biologics Corp. (CSE: MGRO) who have always known that the therapeutic uses of marijuana are yet to be fully documented.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have a questions or are you interested in working with CNW420? Ask our Editor